Buy or sell Nuvaira stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Nuvaira Stock

Develops devices for treating lung diseases

Founded

2008

Headquarters

Plymouth MN, US

Total Funding

$148M

About Nuvaira Stock

Nuvaira, Inc. (formerly Holaira, Inc.), located in Minneapolis, Minnesota is a privately held lung denervation company developing minimally invasive products that aims to make breathing easier for patients suffering from obstructive lung diseases.

Funding History

September 2010$3.0M
May 2011$5.0M
September 2012$10.6M
February 2013$10.0M
April 2014$40.0M
February 2019$79.0M

Management

President and CEO

Dennis Wahr

Founder & CTO

Martin L. Mayse

Director of Regulatory Affairs

Mahtab Fatemi

Vice President Clinical Affairs

Jim Pavliska

CFO

Kari Kubesh

Senior Vice President Operations

Steve Mertens

Board of Directors, President and CEO

Dennis W. Wahr

Vice President International Development

Scott Grant

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Nuvaira or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo